Home

2012 Press Releases

Keyword Search
 
2015 | 2014 | 2013 | 2012 | 2011 | 2010
Investor Resources
TNGN(Common Stock)
ExchangeOTC BB (US Dollar)
Price$0.00
Change (%)-0.00 (NaN%)
Volume93,130
Data as of 01/30/15 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
What's New
December 21, 2012
Tengion Announces Change to Board of Directors
WINSTON-SALEM, N.C., Dec. 21, 2012 /PRNewswire/ -- Tengion, Inc. (OTCQB: TNGN), a leader in regenerative medicine, today announced that Scott D. Flora, President & Chief Executive Officer at OmniGuide, has resigned from Tengion's Board of Directors, effective December 19, 2012. "Scott has been a valuable asset to Tengion and his expertise in the medical and surgical device arenas has been an excellent resource for the Company over the last year," reflected David Scheer, Chairman of the ... 
November 13, 2012
Tengion Provides Business Update and Reports Third Quarter 2012 Financial Results
-- Actively Recruiting Remaining Four Patients in Neo-Urinary Conduit™ Phase 1 Trial -- -- IND Filing for Neo-Kidney Augment™ Expected During First Half of 2013 -- WINSTON-SALEM, N.C., Nov. 13, 2012 /PRNewswire/ -- Tengion, Inc. (OTCQB: TNGN), a leader in regenerative medicine, today reported its financial results for the third quarter ended September 30, 2012 and provided a business update. "We are focused on enrolling the remaining four patients in the Phase 1 trial of our Neo-Urinary...